USD10
CMPS Shares
About Compass PathwaysCompass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
USD10
CMPS Shares
About Compass PathwaysCompass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Stats
TRADING WINDOW
Closed
OPENS AT
Jul 8 at 1:30 PM GMT+0
MARKET CAP
$1.7B
OPEN PRICE
Not enough data
LOW (1Y)
$3.34
HIGH (1Y)
$15.40
LOW (24H)
$10.57
HIGH (24H)
$14.00
VOLUME (24H)
$11.00
100%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $13.05 | |
1 Week | $14.30 | |
1 Month | $11.85 | |
1 Year | $3.53 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.